
http://centerwatch.com/patient/studies/cat102.html
June 9, 2003 at 2:39:24 PM
CenterWatch
Arizona
Phoenix;
Barrow Neurological Institute Clinical Research
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
California
La Jolla;
Center for Neurologic Study
Do you have a hard time controlling your emotions?
Los Angeles;
UCLA Medical Center
A Study of Testosterone Treatment for Men with Multiple Sclerosis
Palo
Alto; Palo Alto Medical Foundation
Avonex Phase IV Clinical Trial
San Francisco;
UCSF Medical Center
Avonex Phase IV Clinical Trial
Florida
Plantation;
Neurology Clinical Research, Inc.
Do you or a loved one suffer from multiple sclerosis?
Georgia
Decatur;
Neurology & Headache Specialist of Atlanta, LLC
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
Illinois
Northbrook;
Consultants in Neurology LTD
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
Indiana
Danville;
Midwest Medical Research
Have you been diagnosed with Multiple Sclerosis?
Montana
Great
Falls; Advanced Neurology Specialists
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
Great
Falls; Advanced Neurology Specialists
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
Nevada
Henderson;
Nevada Neurological Consultants, Ltd.
Diagnosed with Relapsing Remitting MS?
New York
Albany;
Upstate Clinical Research
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
New York;
Mount Sinai Medical Center
5 year study to evaluate use of Novantrone(mitoxantrone) infusions
in Multiple Sclerosis (MS) patients
New York;
Mount Sinai Medical Center
Open-Label Study of the Safety and Effectiveness of Combination Therapy
with Mitoxantrone and interferon b1a or glatiramer
acetate.
New York;
Mount Sinai Medical Center
OMEGA-Oral Megadose Corticosteroid Therapy of Acute Exacerbations in
Multiple Sclerosis
New York;
Mount Sinai Medical Center
IGIV-C (Intravenous Immunoglobulin- Chromatogrpahy) in Relapsing Remitting
Multiple Sclerosis
New York;
Mount Sinai Medical Center
A 20 Week Study to Evaluate the Safety and Tolerability of Fampridine-SR
in Subjects with Multiple Sclerosis
North Carolina
Raliegh;
Raleigh Neurology Associates, PA
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
Ohio
Canton;
NeuroCare Center, Inc.
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
Pennsylvania
Upland;
Neurological Associates of Delaware Valley
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
Washington
Seattle;
Swedish Medical Center / Regional Multiple Sclerosis Center
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
Washington, DC
Washington;
George Washington University Medical Faculty Associates
Individuals diagnosed with multiple sclerosis and have a history of
pathological laughing and / or crying (pseudobulbar affect).
Copyright (c) 1995 - 2003, Thomson Centerwatch